Article and Video CATEGORIES
Dr. Jack West introduces the question of whether third generation EGFR tyrosine kinase inhibitors osimertinib and rociletinib should be used as first line therapy rather than for acquired resistance, including discussing key clinical trials on the topic.
Get more information about the FLAURA Trial and TIGER-1 Trial.
Please feel free to offer comments and raise questions in our
discussion forums.
Forum Discussions
I hope you find some help through your doc or PT.
Take care,
Janine
Hi Revtoby, Welcome to Grace. I'm sorry you and your wife are worried about cancer but we couldn't say whether or not your wife's leison is cancer no matter how much...
Canyil, I'm sorry your father and you are going through this. While we can't give urgent help we are her to help offer info and resources to help make the best...
Hi ramosking, Welcome to Grace. I'm sorry you're suffering. It doesn't sound like you have a pancoast tumor. It does seem like you should see your PCP or a pulmonologist for...